Markets (2020): ~807 in trials
The latter drug is associated with preserved cognitive function and reduced mechanical ventilation duration in patients in the intensive care unit
Do not share pens with others, even if the needle has been changed
Its removal from Category 1 means it is moving into the PCAC review pipeline for a definitive determination rather than remaining in the indefinite "under evaluation" holding pattern
Dunn L, Allen GF, Mamais A, Ling H, Li A, Duberley KE, et al
The most common side effects associated with GLP-1 agonists include appetite loss, nausea, vomiting, and diarrhea, which are often more pronounced when starting the medication or increasing the dosage (4)(10)(23)